Quick Answer
agilon health, inc. reported Cash and Equivalents of $173.71 million for fiscal year 2025.
agilon health, inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $173.71M | -7.7% |
| 2024 | $188.23M | +75.0% |
| 2023 | $107.57M | -76.9% |
| 2022 | $465.30M | -55.3% |
| 2021 | $1.04B | +873.9% |
| 2020 | $106.80M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $171.68M | +15.9% | +0.2% |
| June 30, 2025 | $171.42M | +56.6% | +25.2% |
| March 31, 2025 | $136.94M | +22.6% | -27.2% |
| December 31, 2024 | $188.23M | +75.0% | +27.0% |
| September 30, 2024 | $148.16M | -12.0% | +35.3% |
| June 30, 2024 | $109.49M | -42.7% | -2.0% |
| March 31, 2024 | $111.71M | -71.7% | +3.8% |
| December 31, 2023 | $107.57M | -78.4% | -36.1% |
- agilon health, inc. showed a decrease of -7.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, agilon health, inc.’s cash and equivalents has grown by 62.7% (from $106.80 million to $173.71 million).
- The most recent figure is from agilon health, inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: